Compare DexCom, Inc. (DXCM) vs Packaging Corporation of America (PKG) Price & Performance

DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.

The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.

Packaging Corporation of America (PKG) trades at $231.26, up 2.44% on the day, with a bullish technical signal from moving averages. The company reported mixed quarterly earnings, beating Q1 2026 estimates but missing Q3 and Q4 2025. Fundamentals show solid profitability with an 8.04% net margin and 16.21% ROE, though valuation ratios appear elevated. The company recently announced a 20% dividend increase, signaling confidence in cash generation.

The outlook is cautiously optimistic, supported by analyst consensus and a dividend hike, but tempered by recent earnings misses and margin pressure. Key opportunities include market share gains and operational efficiency, while risks involve input cost inflation, competitive pressures, and potential earnings volatility. The stock trades below the consensus price target of $256.14, suggesting potential upside.